Logo

CGH

In Print: Last Week's Microarray Papers of Note: Apr 2, 2013
Premium

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet. 2013 Apr;45(4):385-91. Eeles R, Olama A, Benlloch S, et al.

Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
Premium

Researchers who set out to compare the ability of SNP and comparative genomic hybridization microarray platforms to detect copy number variation in autusm spectrum disorder managed to identify 16 genes that hadn't been associated with ASD before.

Cancer Genetics to Launch Two New Oncology-Focused CGH Array Tests by Year End
Premium

CHICAGO — Cancer Genetics will later this year expand its menu of array-based tests to include assays for informing treatment of patients with diffuse large B-cell lymphoma and renal cell carcinoma.

With SNP Content on the Rise for Cytogenetics, Do CGH Arrays Have a Future?
Premium

By Justin Petrone

France's ArrayGenomics Rolls out CGH Array for Bladder Cancer Studies
Premium

By Justin Petrone ArrayGenomics recently began selling a comparative genomic hybridization array that it claims can be used to diagnose, grade, and stage bladder cancer based on DNA extracted from urine.
Feb 7, 2012

Roche Reports Drop in Applied Science Sales, Provides Update on Cancer Companion Dx
Premium

Nov 29, 2011

In 'Soft' Array Market, Agilent Hangs on to CGH Business, But Loses Ground in Expression
Premium

Sep 13, 2011

Ambry Debuts New Cytogenomic Cancer Dx Chips; OGT, Signature Ready Theirs
Premium

Aug 30, 2011

Carver Center for Genomics Certified to Offer Roche NimbleGen Array Services
Premium

May 24, 2011

Agilent Taps NIMGenetics to Sell Its CGH/SNP Arrays in Spain
Premium

May 18, 2011

NIMGenetics Becomes Agilent's First CSP in Spain

May 17, 2011

Spanish Researchers Develop 'Short CGH' Approach for Preimplantation Genetic Screening
Premium

Mar 29, 2011

UK Researchers to Use Agilent, Illumina Chips in 12,000-Sample Developmental-Disorders Project
Premium

Mar 23, 2011

Mouse Cancer Genome Highlights Mutations Relevant to Human Disease

Feb 15, 2011

Oxford Gene Technology Secures ISO 17025 Accreditation for CGH Services
Premium

Jan 4, 2011

In 2010, Array Makers Saw CGH Become the Standard in Cytogenetics, Prepared for Next Wave of GWAS
Premium

Oct 19, 2010

Roche NimbleGen Q3 Sales Rise 22 Percent on Rising Sequence Capture, Array CGH Demand
Premium

Sep 28, 2010

ACMG Recommends Replacing Karyotyping with Chromosomal Microarrays as 'First-Line' Postnatal Test
Premium

Sep 21, 2010

Despite Streamlining Operations, Enzo Biochem Plans to Expand Array-CGH Labeling Offering
Premium

Sep 14, 2010

Agilent to Debut New CGH and SNP Arrays to Support Cyto, Cancer Research
Premium

Jul 20, 2010

Roche NimbleGen, Preparing Cyto Array FDA Submission, Eyes Opportunities in Oncology Dx
Premium

Jul 13, 2010

Macrogen Named Roche NimbleGen CSP

Jun 22, 2010

Signature Genomics, Now Part of PerkinElmer, Sets Sights on Oncology, Neuropsychiatric Testing
Premium

Jun 22, 2010

OvaGene Opens Clinical, Research Lab

Jan 26, 2010

Q&A: ISU's Patrick Schnable on Decoding Maize Genomic Diversity Using Array CGH
Premium

Breaking News
The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.